Konstantin Matentzoglu, Supervisory Board Member of Polpharma Biologics Group, said: “We are proud to extend our ...

It feels like everyone is talking about ‘how they’re using it’ but we’ve found that only 13% of pharma leaders feel ‘very prepared’ to implement AI across ...

Ongoing drug safety monitoring is critical not only for regulatory compliance and risk management but also to maximise the benefits of products for patients.

Rethinking diversity, equity and inclusion (DEI) in pharma means going beyond the expected.

Throughout the morning, Sarah presses on but faces mounting difficulty in meetings. The office lights seem harsher and a throbbing, pulsing headache occurs on one side of her head. By lunchtime, ...

eXmoor Pharma and Anthony Nolan: Cell Therapy & Laboratory Services (CT&LS) have announced a strategic partnership to provide integrated support for developers of autologous and allogeneic cell ...

Toby Eyre, Consultant Haematologist at Oxford University Hospital NHS Foundation Trust, said: “As a newly licensed treatment option, pirtobrutinib provides an additional treatment option for eligible ...

Eisai and Biogen have announced FDA approval of LEQEMBI IQLIK (lecanemab-irmb) for maintenance dosing in early Alzheimer’s disease. The subcutaneous autoinjector delivers a 360 mg dose in ...

Novartis has reported that its experimental drug ianalumab met the primary goal in a phase 3 trial for primary immune ...

Situated in nearby Rockville, MD, SMP Pharmacy specializes in fertility services. With 24/7 support and a personalized ...

The US Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application from Coya Therapeutics for COYA 302, enabling the company ...

Swedish biotech company Akiram Therapeutics has announced significant progress in its first clinical trial of AKIR001, a ...